Debora Barton
Director/Board Member at AROVELLA THERAPEUTICS LIMITED
Net worth: 21 360 $ as of 2024-04-29
Profile
Debora Barton is an Independent Non-Executive Director at Arovella Therapeutics Ltd.
since 2021.
She is also a Director at the American Cancer Society, Inc. since 2018.
Previously, she served as the Senior VP, Head-Clinical & Safety at Iovance Biotherapeutics, Inc. from 2018 to 2019.
From 2019 to 2022, she held the position of Chief Medical Officer at both CTx Operations, Inc. and Carisma Therapeutics, Inc. Currently, she is the Chief Medical Officer at TScan Therapeutics, Inc. starting from 2022.
Dr. Barton obtained a doctorate degree from Pontifícia Universidade Católica de São Paulo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 263,157 ( 0.03% ) | 21 360 $ | 2024-04-29 | |
TSCAN THERAPEUTICS, INC.
-.--% | 2024-03-30 | 0 ( -.--% ) | - $ | 2024-04-29 |
Debora Barton active positions
| Companies | Position | Start |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Director/Board Member | 2021-08-09 |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Director/Board Member | 2018-04-30 |
Former positions of Debora Barton
| Companies | Position | End |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-04-07 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 2022-05-31 |
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-05-31 |
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-10-31 |
Training of Debora Barton
| Pontifícia Universidade Católica de São Paulo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AROVELLA THERAPEUTICS LIMITED | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Commercial Services |
- Stock Market
- Insiders
- Debora Barton
